05Jun Date June 5, 2026 Tags Biosimilar Development, Biosimilars, CDSCO, ICH E6 R3, India UK Biosimilar Corridor, Pharmacovigilance, Regulatory affairs, UK Biosimilar Approval MHRA Approval, UK Clinical Trials Categories Clinical Research OrganizationIndia – UK Biosimilar Corridor: A Controlled Evidence PathwayIndia - UK Biosimilar Corridor: A Controlled Evidence Pathway NHS England's Commissioning Fram...
09Apr Date April 9, 2026 Tags Bioequivalence studies, Clinical Trials, CRO services, Diabetes treatment, Generic drug development, GLP-1 receptor agonist, Obesity treatment, Patent expiration, Peptide drugs, Pharmaceutical industry, Regulatory affairs, Semaglutide Categories Clinical Research Organization, Clinical OperationsSemaglutide: From Blockbuster Innovation to a Global Generic OpportunitySemaglutide: From Blockbuster Innovation to a Global Generic Opportunity (Discover how Semaglu...